Ciela Kerr

GSK is a leading and growing global company driven by the purpose to unite science, technology and talent to get ahead of disease together. We have clear ambitions to positively impact the health of billions across the world. Our focus is on the science of the immune system, human genetics and advanced technologies, in four core therapeutic areas: Infectious disease, HIV, Oncology and Immunology/Respiratory. We support investments and prioritize innovation in Vaccines and Specialty Medicines, maximizing opportunities that are increasingly evident across prevention and treatment of disease. Pursuing a growth-oriented capital allocation policy enables a strengthened balance sheet. We deliver this performance whilst meeting the high standards expected of us, as well as driving a culture of ambition, accountability and responsibility.